Grappling With High Triglycerides and Atherosclerotic Risk
Prevention and treatment of dyslipidaemias represent a fundamental part of cardiovascular disease prophylaxis. Consequently, the effective management of different types of lipid disorders, including hypertriglyceridaemia, should be a priority for healthcare practitioners and their patients.
Modern Medicine ā Issue 3 2023
How to Manage Substance Use Disorder
The use of substances has been prevalent for many centuries. Many people across the world use substances for various cultural, religious and recreational reasons. These products are often said to be ānaturalā, owing to their predominantly plant-based nature.
Modern Medicine ā Issue 3 2023
Complementary and Alternative Medicine ā an Often Unspoken Topic
Because the newer methods of treatment are good, it does not follow that the old ones were bad: for if our honourable and worshipful ancestors had not recovered from their ailments, you and I would not be here today. āConfucius (c. 551ā478 BCE)
Modern Medicine ā Issue 3 2023
Know Your Patientsā Iron Status
Anaemia affects one-third of the world population with iron deficiency anaemia (IDA) being the top cause. IDA is highly prevalent in preschool children (< 5 years), women in the reproductive age, and pregnant women, with prevalence rates reaching up to 41.7%, 32.8% and 40.1%, respectively.
Modern Medicine ā Issue 3 2023
The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition:
Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online.
Managing Depression: Using a clinical practice guideline approach
The 2020 update of the Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders provides a new framework for managing depressive disorders that moves beyond the stepped care approach. This framework is based around three key components: actions, such as lifestyle modification and patient education; choices in pharmacological treatment that include the patientās preferences; and potential alternative treatments.
Modern Medicine āĀ Issue 2 2023
Reviving Assisted Delivery Options Lessens Need for C-sections
When indicated for health reasons, caesarean section (CS) is an important surgical intervention to save lives of women and children. However, unnecessary CS (without medical/ obstetric indication) should be avoided, as maternal mortality is three times higher for CS than for normal vaginal delivery, which is associated with fewer complications and is more sustainable for healthcare systems.
Modern Medicine ā Issue 2 2023
Obesity and Diabetes: (Un)comfortable Bedfellows
The term pandemic has been bandied about freely over the past three years with the advent of the COVID pandemic. Although the term refers to an āepidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of peopleā, it may have had its origins in virology and infectious diseases, the description is equally as appropriate to describe the large numbers of people living with type 2 diabetes mellitus (T2DM) and people living with obesity.1 In fact, COVID highlighted the metabolic and pro-inflammatory states that are the hallmark of these two conditions.
Modern Medicine ā Issue 2 2023
Thyroid hormone is the mainstay of therapy for patients with hypothyroidism. The correlation between biochemical parameters, clinical parameters, and satisfaction with thyroid hormone therapy has been a subject of spirited discussion for some time.
Modern Medicine ā Issue 2 2023
Add-on Fibratesā Cardio Protection Still Evident Years On
The extended follow-up study (ACCORDION) of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study, evaluated the ālegacy effectsā of fibrate add-on therapy on mortality and major cardiovascular outcomes in patients with dyslipidaemia. Fibrate treatment during the initial trial period was associated with a legacy benefit of improved survival over a post-trial follow-up. This is a shortened version of the original article.
Modern Medicine ā Issue 2 2023
